This story was originally published by the WND News Center.
Robert F. Kennedy Jr., President Trump's Health and Human Services secretary, has announced COVID booster shots are being removed from the CDC's recommended immunization schedule for healthy children and healthy pregnant women.
"I couldn't be more pleased to announce that as of today, the COVID vaccine for healthy children and healthy pregnant women has been removed from the CDC's recommended immunization schedule," he explained. "Last year the Biden administration urged healthy children to get yet another COVID shot despite the lack of any clinical data to support the repeat booster strategy in children."
He was joined in the announcement by Jay Battacharya, the chief of the National Institutes of Health, who said the move is "common sense and it's good science."
A report from the Daily Mail suggested the change will affect millions of Americans.
The report explained, "The recommendation for the COVID vaccine for young and healthy individuals has long been criticized, given that the groups face a low risk of hospitalization and death from the virus."
Further, the report said, there are the COVID shot side-effects, "including myocarditis — or heart inflammation — which is rare, but slightly more common among young adults."
The Food and Drug Administration just days ago confirmed that annual COVID updates no longer will get automatic approval, and drug companies standing to profit from them must do clinical trials to document whether they are safe or not.
Only 23% of those eligible for the 2024 booster, ages six months and over, took it.
According to an analysis in Ars Technica, eventually only people ages 65 and older and people with underlying conditions that put them at risk are expected to take the "seasonal boosters."
The Food and Drug Administration just days ago confirmed that annual COVID updates no longer will get automatic approval, and drug companies standing to profit from them must do clinical trials to document whether they are safe or not.
Only 23% of those eligible for the 2024 booster, ages six months and over, took it.
According to an analysis in Ars Technica, eventually only people ages 65 and older and people with underlying conditions that put them at risk are expected to take the "seasonal boosters."
"The move was laid out in a commentary article published today in the New England Journal of Medicine, written by Trump administration FDA Commissioner Martin Makary and the agency's new top vaccine regulator, Vinay Prasad," the report explained.
The two explained in the commentary that a "one-size-fits-all" ideology presumes that Americans are unable to understand age- and risk-related recommendations.
The report said, "Under Makary and Prasad's new framework, seasonally updated COVID-19 vaccines can continue to be approved annually using only immunology studies—but the approvals will only be for people age 65 and over and people who are at high risk. These immunology studies look at antibody responses to boosters, which offer a shorthand for efficacy in updated vaccines that have already been through rigorous safety and efficacy trials."
It continued "Moving forward, if a vaccine maker wants to have their COVID-19 vaccine also approved for use in healthy children and healthy adults under age 65, they will have to conduct large, randomized, placebo-controlled studies. These may need to include tens of thousands of participants, especially with high levels of immunity in the population now."
